← Back to Search

Treatment for Desmoplastic Small Round Cell Tumor

N/A
Recruiting
Led By Emily Slotkin, MD
Research Sponsored by Memorial Sloan Kettering Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 7 years
Awards & highlights

Summary

This study is a patient registry of people with Desmoplastic Small Round Cell Tumor (DSRCT). A patient registry is a collection of health information about a group of people, and it is usually focused on a specific diagnosis or disease. The purpose of this registry is to create a database- a collection of information-or better understanding DSRCT. Researchers will use the information from this database to learn more about DSRCT and for current and future research on DSRCT.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~7 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 7 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Registry to Collect Health Information About Desmoplastic Small Round Cell Tumor

Find a Location

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterLead Sponsor
1,956 Previous Clinical Trials
595,306 Total Patients Enrolled
4 Trials studying Desmoplastic Small Round Cell Tumor
115 Patients Enrolled for Desmoplastic Small Round Cell Tumor
Emily Slotkin, MDPrincipal InvestigatorMemorial Sloan Kettering Cancer Center
8 Previous Clinical Trials
308 Total Patients Enrolled
4 Trials studying Desmoplastic Small Round Cell Tumor
115 Patients Enrolled for Desmoplastic Small Round Cell Tumor
~114 spots leftby Dec 2027